| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 15.383 | 42.757 | 11.598 | 59.424 | 53.335 | 144.503 |
| Total Income - EUR | - | - | - | - | 15.530 | 43.074 | 11.865 | 60.013 | 54.078 | 145.646 |
| Total Expenses - EUR | - | - | - | - | 3.212 | 1.149 | 1.347 | 5.322 | 14.323 | 112.316 |
| Gross Profit/Loss - EUR | - | - | - | - | 12.318 | 41.925 | 10.518 | 54.691 | 39.754 | 33.330 |
| Net Profit/Loss - EUR | - | - | - | - | 11.944 | 40.715 | 10.169 | 53.767 | 39.229 | 28.981 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Deaclinic Prof S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 1.868 | 1.329 | 920 | 678 | 1.550 |
| Current Assets | - | - | - | - | 12.079 | 39.433 | 9.170 | 55.646 | 39.151 | 34.246 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1.086 |
| Receivables | - | - | - | - | 707 | 17.229 | 4.298 | 28.167 | 30.240 | 32.302 |
| Cash | - | - | - | - | 11.372 | 22.205 | 4.872 | 27.480 | 8.911 | 858 |
| Shareholders Funds | - | - | - | - | 11.986 | 40.765 | 10.217 | 53.815 | 39.277 | 29.029 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 93 | 537 | 281 | 2.751 | 552 | 6.804 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Deaclinic Prof S.r.l.